# P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine

> **NCT02001012** · PHASE3 · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 123 (actual)

## Conditions studied

- Uncomplicated Knowlesi Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine combination
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT02001012
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-03
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2017-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001012, "P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02001012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*